These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 2886638
1. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum. Consolo S, Wu CF, Fusi R. J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638 [Abstract] [Full Text] [Related]
2. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ. J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [Abstract] [Full Text] [Related]
3. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. Damsma G, Robertson GS, Tham CS, Fibiger HC. J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058 [Abstract] [Full Text] [Related]
4. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide. Suarez-Roca H, Lovenberg T, Cubeddu LX. J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346 [Abstract] [Full Text] [Related]
5. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [Abstract] [Full Text] [Related]
6. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals. Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX. J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641 [Abstract] [Full Text] [Related]
7. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. DeBoer P, Abercrombie ED. J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558 [Abstract] [Full Text] [Related]
8. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738 [Abstract] [Full Text] [Related]
9. Inhibition of the electrically evoked release of [3H]acetylcholine in rat striatal slices: an experimental model for drugs that enhance dopaminergic neurotransmission. Baud P, Arbilla S, Langer SZ. J Neurochem; 1985 Feb; 44(2):331-7. PubMed ID: 2981280 [Abstract] [Full Text] [Related]
10. Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine. Gifford AN, Johnson KM. J Pharmacol Exp Ther; 1992 Nov; 263(2):757-61. PubMed ID: 1359115 [Abstract] [Full Text] [Related]
11. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT, White FJ. Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [Abstract] [Full Text] [Related]
12. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK, Manzino L, Heikkila RE. J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [Abstract] [Full Text] [Related]
13. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. Tedford CE, Crosby G, Iorio LC, Chipkin RE. Eur J Pharmacol; 1992 Feb 11; 211(2):169-76. PubMed ID: 1535318 [Abstract] [Full Text] [Related]
14. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC. J Pharmacol Exp Ther; 1993 Mar 11; 264(3):1344-51. PubMed ID: 8095550 [Abstract] [Full Text] [Related]
17. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum. Hársing LG, Vizi ES. Pol J Pharmacol Pharm; 1985 Apr 11; 37(3):383-96. PubMed ID: 2866504 [Abstract] [Full Text] [Related]
18. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval. De Boer P, Damsma G, Schram Q, Stoof JC, Zaagsma J, Westerink BH. Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb 11; 345(2):144-52. PubMed ID: 1349159 [Abstract] [Full Text] [Related]
19. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL. J Pharmacol Exp Ther; 1993 Aug 11; 266(2):557-62. PubMed ID: 8102643 [Abstract] [Full Text] [Related]
20. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release. Hoffmann IS, Talmaciu RK, Cubeddu LX. J Pharmacol Exp Ther; 1986 Aug 11; 238(2):437-46. PubMed ID: 2942676 [Abstract] [Full Text] [Related] Page: [Next] [New Search]